Andreas Bergmann

AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany.

4teen4 Pharmaceuticals GmbH engages in the research and development in diagnostic and therapeutics bio markets. The company was founded by Andreas Bergmann in 2013 and is headquartered in Hennigsdorf, Germany.

MS Unisea GmbH & Co. KG provides sea and coastal freight transportation services. The private company is based in Haren, Germany. The CEOs of the German company are Andreas Bergmann, Bernhard Held.

MS Unistream GmbH & Co. KG provides warehousing services. The private company is based in Haren, Germany. The CEOs of the German company are Andreas Bergmann, Bernhard Held.

PAM Theragnostics GmbH is a German biotech company that aims to develop a reliable tool for early diagnosis of Alzheimer's disease. PAM Theragnostics is based in Hennigsdorf, DE. The company's long-term vision is to provide safe and cost-effective therapy for Alzheimer's patients. Andreas Bergmann is a visionary who has launched and co-founded several successful biotech companies, including Sphingotec GmbH, 4teen4, and Adrenomed AG. The company was founded by Andreas Bergmann, who has been the CEO since incorporation.

in.vent DIAGNOSTICA GmbH engages in the development and production of in vitro diagnostics. It specializes in the procurement, processing and distribution of human biological materials. The firm also manufactures long-term control materials for internal quality assurance purposes which are used in medical laboratory routines. The comapny products include InQualiCheck, serum and plasma, tissue and proteins and antibodies. in.vent DIAGNOSTICA was founded in 1997 and is headquartered in Hennigsdorf, Germany.

B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany.

Part of Reaction Biology Corp., Bioassay Labor für biologische Analytik GmbH is a contract service organization based in Heidelberg, Germany. The German company specializes in the development and validation of bioassays for pharmaceutical potency testing, with services performed under GMP and GLP certification to meet regulatory guidance for pre-market and on-market products. The company was founded by Andreas Bergmann and the CEOs are Axel Hohenstein and Sven-Michael Cords. Bioassay Labor für biologische Analytik GmbH was acquired by Reaction Biology Corp. on December 02, 2022.